Of mitochondrion and COVID-19

• Main Authors: Khalid Omer Alfarouk (Author), Sari T. S. Alhoufie (Author), Abdelhameed Hifny (Author), Laurent Schwartz (Author), Ali S. Alqahtani (Author), Samrein B. M. Ahmed (Author), Ali M. Alqahtani (Author), Saad S. Alqahtani (Author), Abdel Khalig Muddathir (Author), Heyam Ali (Author), Adil H. H. Bashir (Author), Muntaser E. Ibrahim (Author), Maria Raffaella Greco (Author), Rosa A. Cardone (Author), Salvador Harguindey (Author), Stephan Joel Reshkin (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

COVID-19, a pandemic disease caused by a viral infection, is associated with a high mortality rate. Most of the signs and symptoms, e.g. cytokine storm, electrolytes imbalances, thromboembolism, etc., are related to mitochondrial dysfunction. Therefore, targeting mitochondrion will represent a more...